The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Adenoid Cystic Carcinoma Research Foundation
P.O. Box 442
Needham, MA 02494
The Adenoid Cystic Carcinoma Research Foundation (ACCRF) is a voluntary, non-profit organization whose mission is to support research that will expedite the development of improved therapies and a cure for adenoid cystic carcinoma (ACC). ACCRF works toward its mission by creating a community of interested researchers that follows an innovative plan of action. In the furtherance of its mission, the Foundation does support broader efforts focused on salivary gland tumors. Major programs center on biobanking, model system development, genomics and drug screening. ACC is a relatively rare form of cancer that most commonly develops in the salivary glands or other regions of the head and neck. In some cases, ACC may arise in other primary sites, such as the skin; the breast; the neck of the uterus (cervix) in females; the prostate gland in males; or other areas.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.